Congress

Mabqi participates to several events in 2025

August 28, 2025

MabQi Strengthens International Scientific Presence Through 2025

Meet us at the Antibody Engineering and Therapeutics Conference in San Diego – Dec 12-16 2021

Meet us during PEGS Boston – May 11-13, 2021

Mabqi is a biotechnology company focused on the discovery and development of fully human antibodies. Leveraging an innovative platform, we specialize in uncovering monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), pH-sensitive antibodies, and various other immunotherapy formats.

Contact Us

Legal notice

-

Privacy policy